Prof. Gopal C. Kundu has obtained his Ph.D. degree in Chemistry from Bose Institute, Kolkata, India (1989). He did his post-doctoral work at The Cleveland Clinic Foundation, University of Colorado at Boulder, University of Wyoming and The National Institutes of Health, USA in the area of cardiovascular research, inflammatory diseases and reproductive biology from 1989 to 1998. He then joined as Scientist-D at National Centre for Cell Science (NCCS) in 1998 and then promoted to Scientist-E, -F and –G from 1998 to 2019. He also served as Dean, Acting Director and Director (i/c) at National Centre for Cell Science, Pune, India from 2018-2019. Currently, Prof. Kundu is Director, R&D of KIIT Deemed to be University (KIIT DU), Institute of Eminence, Bhubaneswar, India. He holds additional charge as Professor of Biotechnology, School of Biotechnology (KIIT DU) and Professor of Medicine and Molecular Research, Kalinga Institute of Medical Science (KIMS), KIIT DU, Bhubaneswar, India.

Academic and Research Achievements: Prof. Gopal C. Kundu has initiated several programs largely addressing the biology of cancer including breast cancer. He is studying to understand various aspects of cancer biology holistically like regulation of gene expression, targeted drug delivery and drug development, angiogenesis, cancer stem cells, nanotechnology and chemical biology based approaches, tumor-stromal interaction and cancer therapeutics. Among the peers, his contribution is recognized internationally and very well adored. 

Tumor microenvironment (TME) consists of various cellular players including extracellular matrix (ECM), hypoxia, fibroblasts, neuroendocrine (NE) cells, adipose cells, immune-inflammatory cells etc. These components play crucial role in tumor growth, immune evasion, metastasis and angiogenesis. Prof Kundu has extensively studied the complex mechanisms and dissected the cancer signaling pathways and their cross-talks during the progression of breast and other tumors at primary sites, angiogenesis and metastasis. His pioneering and novel research accomplishments are published in very high impact reputed journals including Nature Medicine, Science, PNAS (USA), Cancer Research, J. of Invest. Dermatology, J. of Biol. Chem, Trends in Cell Biol., Oncogene, Nanomedicine (London), Molecular Cancer, Nanoscale, Carcinogenesis, EMBO Reports, Advanced Functional Materials, BMC Cancer, Communication Biology, FRBM etc and one US patent and filed five Indian Patients. His total publications are 119, citations are 9,275 , h-index of 54 and i-10 index of 96.

Other Contributions: Prof. Gopal C. Kundu is Associate Editor of Molecular Cancer (IF: 41.44) and the only member from India. He serves as Editorial Board Member of Current Molecular Medicine, Current Chemical Biology, International Journal of Oncology, Molecular Medicine Reports, American Journal of Cancer Research, Frontiers in Medicine, World Academy of Sciences Journal, Frontiers in Cell & Development Biology: Cancer Biology and Associate Editor of Journal of Cancer Metastasis and Treatment (JCMT). Prof. Kundu served as Adjunct Visiting Professor at Curtin University, Perth, Australia (2015-2019).

He is involved in accelerating multiple interdisciplinary research across various schools of KIIT DU including KSBT, SAS, SOT, KIMS and KIDS etc. He is the Executive Secretary of Indian Society for Translational Research (ISTR), which actively organises conferences and workshops to promote translational research across the country.

Awards and Honours: Prof. Kundu has been elected as a Fellow of Indian National Science Academy. He is Fellow of National Academy of Sciences and Indian Academy of Sciences. Recently he has been elected as a fellow of Royal Society for Chemistry (RSC). Prof Kundu has received several awards including Fellows Award for Research Excellence from NIH, USA in 1997; National Bioscience Award from Department of Biotechnology, Ministry of Science & Technology, Govt. of India in 2003; Shanti Swarup Bhatnagar Prize (highest honor in Science by Govt. of India) from Council of Scientific and Industrial Research (CSIR), Ministry of Science & Technology, Govt. of India in 2004; International Award in Oncology from Greece in 2007; International Young Investigator Award from Mayo Clinic, USA in 2012, Platinum Jubilee Award, 99^th Indian Science Congress, India in 2012 and 7th National Grassroots Innovation Award from Rashtrapati Bhavan, India in 2013. Prof Kundu has received NASI Platinum Jubilee Senior Scientist Fellowship in 2020 (not availed). He received the Shri R.J. Kinariwala Research Award for Life Time Research Achievement in Cancer Research form Gujarat Cancer Research Institute (GCRI), India in 2020. The International Journal of Oncology, Greece has published his lifetime work as an Autobiography & Career Achievements as Editorial Academy Member in the Cover page of this journal in May, 2021. Prof. (Dr.) Achyuta Samanta, Founder of KIIT and KISS has awarded him in 2022 for undertaking highest number of research projects at KIIT University, funded by Govt. of India and the Indo-German, ICMR international program.